Former Israeli Prime Minister Ehud Barak to Deliver Opening Keynote Address at CannaTech Tel Aviv 2019
Monday, April 1, 10:00 am
Tel Aviv, Israel, the Global Capital of Cannabis R&D
March 19, 2019 (Investorideas.com Newswire) Tel Aviv, Israel, March 19, 2019…Former Israeli Prime Minister Ehud Barak will be the opening keynote speaker at CannaTech Tel Aviv 2019, Israel's premier Medical Cannabis conference, on Monday, April 1, in Tel Aviv, the global capital of medical cannabis.
The event will take place at Trask & Reading 3 at the Tel Aviv Port.
Prime Minister Barak is the Chairman of CANNDOC/InterCure, a holding company of Israeli medical cannabis firms. His keynote speech, "From Government to Cannabis: A Former Prime Minister's View of the Importance of Medical Cannabis in the Global Political Arena" will be heard by over 1,000 participants spanning every continent, who will come together in Tel Aviv to learn about the latest scientific and business developments in the burgeoning cannabis field.
Economists foresee the potential overall market worth of cannabis related goods and products in the tens of billions of dollars in the next decade as global demand surges and more countries throughout the world legalize the use of the plant.
Saul Kaye, Founder and CEO of CannaTech and iCAN Israel-Cannabis said: "I am thrilled that Prime Minister Barak will join the world's foremost thought-leaders in science and business at CannaTech Tel Aviv. His participation is testament to ever-increasing significance of the cannabis market worldwide and Israel's key place in the industry. Since the Israeli government just recently allowed medical cannabis export, interest in the nation's unsurpassed cannabis eco-system has dramatically increased, making CannaTech Tel Aviv, literally, the most important cannabis meeting place in the world. Israel is prepared to help tens of millions of patients in need and I could not be prouder to showcase the advances we have made. I very much appreciate the gravitas that Prime Minister Barak brings to CannaTech and the industry in general."
MARCH 31: SCIENCE AND BUSINESS SYMPOSIUM
Two full day in-depth informational sessions highlighting the brightest minds in medical cannabis:
- Cannabis plant science and medical research
- Cannabis business, industry and finance
APRIL 1-2: CANNATECH TEL AVIV 2019
The two-day conference will cover diverse topics from all sectors of the medical cannabis ecosystem including:
- Latest regulatory and compliance standards
- Next wave of targeted cannabis-based therapies and devices
- Novel cultivation and delivery systems to improve the quality and efficacy of cannabis medicine
To learn more about CannaTech Tel Aviv 2019, purchase tickets and subscribe to event updates and speakers lists click here. To learn about iCAN, the conference's organizers, click here for the iCAN website.
About iCAN: Israel-Cannabis
iCAN: Israel-Cannabis is building the Global Cannabis Ecosystem. iCAN is committed to accelerate Israel's Canna-Technology industry, capitalizing on Israeli innovation and a leading cannabis regulatory environment to bring premier products to market. iCAN is powered by CannaTech, the premier international cannabis summit held annually in Tel Aviv, and around the world including London, Sydney, Hong Kong, Panama and soon Africa later in 2019.
CannaTech is the only Medical Cannabis event of its kind with a global focus that offers senior industry leaders, medical and scientific experts, and new ventures the platform to come together, drive innovation, form partnerships and promote knowledge exchange.
InterCure (CANDOCC Pharma) is the first and only public company on the Tel Aviv Stock Exchange (TASE: INCR), which holds a valid and permanent license for the entire medical cannabis value chain. The company has recently acquired full ownership and control (100%) of CANNDOC Pharma, a leading pioneer in the medical cannabis sector in Israel and worldwide, and has been in engaged in ten years of research, nurturing, cultivating and marketing medical cannabis to thousands of patients with a range of indications that have been approved by Israel's Ministry of Health and collaborate with partners in Israel and abroad. Visit https://www.canndoc.co.il
For further information about media coverage, interviewing CannaTech organizers and speakers or for press registration contact Laura Kam, email@example.com; +972-54-806-8613.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com